天津医药

• 实验研究 •    

阿托伐他汀抑制肝癌细胞增殖作用的研究

刘蔚,张连峰,张宇恒   

  1. 郑州大学第一附属医院消化内科
  • 收稿日期:2009-09-07 修回日期:2010-01-07 出版日期:2010-06-15 发布日期:2010-06-15
  • 通讯作者: 刘蔚

Effects of Atorvastatin on proliferation and expression of COX-2 protein in hepatic cancer cells

  • Received:2009-09-07 Revised:2010-01-07 Published:2010-06-15 Online:2010-06-15

PDF (PC)

1887

摘要： 摘要　目的：体外观察阿托伐他汀对人肝癌HepG2细胞增殖、细胞周期及COX-2蛋白表达的影响。方法：取对数期人肝癌HepG2细胞，加入阿托伐他汀使其终浓度为0μM、0.1μM、1μM、10μM、100μM，采用细胞计数法及噻唑蓝(MTT)法观察阿托伐他汀对HepG2细胞增殖的影响，流式细胞仪(FCM)研究阿托伐他汀对细胞周期的作用，免疫细胞化学观察阿托伐他汀对COX-2蛋白表达的影响。结果：1.体外阿托伐他汀呈浓度和时间依赖性地抑制HepG2细胞的增殖，但0.1μM组与0μM组差异无统计学意义。2. 细胞周期分析显示，阿托伐他汀作用24h后，呈浓度依赖性改变细胞周期分布，一方面增高G0/G1期细胞的比例，一方面降低S期及G2/M期的细胞比例，但细胞凋亡不明显。3.体外阿托伐他汀呈浓度依赖性地抑制HepG2细胞COX-2蛋白的表达。结论：体外阿托伐他汀对HepG2细胞增殖有抑制作用，该作用可能与使细胞生长阻滞于G0/G1期及抑制COX-2蛋白表达有关。

关键词: 阿托伐他汀, 细胞周期, 肝癌, COX-2

Abstract: 【Abstract】　Objective　To investigate the effect of atorvastatin on the proliferation , cell cycle and COX-2 protein expression of human hepatocellular carcinoma (HepG2) cells in vitro.Methods　 The human hepatocellular carcinoma HepG2 cells were employed during logarithmic growth phase and atorvastatin were administrated and the final concentrations were 0, 0.1μM,1μM,10μM,100μM respectively. Proliferation of the cells was detected by cell counting and MTT assay ,cell cycle was measured by flowcytometry (FCM), COX-2 protein expression was detected by immunocytochemistry. Results　1 Atorvastatin suppressed growth of HepG2 cells in a dose- and time-dependent manner. There was no significant difference between 0.1μM group and 0μM group. 2.Cell cycle analysis revealed that atorvastatin caused a dose-dependent increase of cells in G0/G1 phase of the cell cycle. At the same time the cells in S and G2/M phase were decreased.However, apoptosis in HepG2 cells was not obvious. 3.Atorvastatin inhibited COX-2 protein expression in a dose-dependent manner. Conclusion　Atorvastatin inhibited HepG2 cells growth in vitro, which may be related with its inhibitory effect on COX-2 protein expression and arresting HepG2 cells at G0/G1 phase of cell cycle.

Key words: Atorvastatin, Cellcycle, hepatic cancer, COX-2